Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Upstart’s Breakout May Occur Sooner Than Expected – H2 2026 Macro Risks (NASDAQ:UPST)

1 September 2026

Ametek: The Quiet Control Layer Behind The Next Industrial Investment Cycle (NYSE:AME)

1 September 2026

Top 25 Dividend Stock Opportunities For September 2026

1 September 2026

Cango Inc. (CANG) Q2 2026 Earnings Call Transcript

1 September 2026

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

1 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 1
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Transcript
News

ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk5 June 20262 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Share
Facebook Twitter LinkedIn Pinterest Email

ResMed Inc. (RMD) 46th Annual William Blair Growth Stock Conference June 2, 2026 5:40 PM EDT

Company Participants

Michael Farrell – CEO & Chairman

Conference Call Participants

Brandon Vazquez – William Blair & Company L.L.C., Research Division

Presentation

Brandon Vazquez
William Blair & Company L.L.C., Research Division

Hello, everybody. My name is Brandon Vazquez. For those of you who I haven’t met before, I’m 1 of William Blair’s medical device analyst, also cover animal health for the firm. I am required to inform you for a complete list of research disclosures and potential conflicts of interest go to williamblair.com.

And with that, I am happy to say that we have the ResMed team here. We have Mick Farrell, the CEO; and Aaron Bloomer, the new CFO. Happy to join us here. They’re going to give us a corporate presentation as many of the — as we’ve been doing all day. We will actually stay in this room for the breakout session, so at the end, I’ll come up here. I might give us like 5 minutes to let people trickle in if they’re coming from another session. And then we’ll do Q&A here.

With that, I’ll turn it over to Mike.

Michael Farrell
CEO & Chairman

Excellent. Well, thanks. And I’ve got the time here, so I’ll stick pretty closely to the 29 minutes they got me here on the presentation. Look forward to a lot of questions and a good discussion around sleep health, breathing health and the health care technology delivered at home.

Forward-looking statements, you can read on your own.

Yes, ResMed is the global leader in the field of connected health and digital health. We have over 26 billion nights of medical data in the cloud. Over 30 million 100% cloud connectable medical devices sold in over 144 countries

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Upstart’s Breakout May Occur Sooner Than Expected – H2 2026 Macro Risks (NASDAQ:UPST)

Ametek: The Quiet Control Layer Behind The Next Industrial Investment Cycle (NYSE:AME)

Top 25 Dividend Stock Opportunities For September 2026

Cango Inc. (CANG) Q2 2026 Earnings Call Transcript

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

Pzena Focused Credit Opportunities Q2 2026 Commentary

Editors Picks

Ametek: The Quiet Control Layer Behind The Next Industrial Investment Cycle (NYSE:AME)

1 September 2026

Top 25 Dividend Stock Opportunities For September 2026

1 September 2026

Cango Inc. (CANG) Q2 2026 Earnings Call Transcript

1 September 2026

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

1 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

1 September 2026

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

1 September 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

31 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.